These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33124944)

  • 1. Fluoroquinolone Resistance Among Isolates of
    Ali S; Khan MT; Khan AS; Abbas Q; Irfan M
    Microb Drug Resist; 2021 Jun; 27(6):786-791. PubMed ID: 33124944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
    Mamatha HG; Shanthi V
    J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
    Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
    Jabeen K; Shakoor S; Malik F; Hasan R
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Multi-Drug Resistant
    Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
    Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Tudó G; Lopez-Gavin A; Portell-Buj E; Freixes J; Vila J; Roman A; Monté MR; Gonzalez-Martin J
    Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru.
    Schwalb A; Cachay R; Meza E; Cáceres T; Blackman A; Maruri F; Sterling TR; Gotuzzo E
    BMC Res Notes; 2021 Nov; 14(1):413. PubMed ID: 34776013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant
    Sun Q; Cheng K; Liao X; Zhao W; Wang C; Wang C; Yan J; Dong L; Wang F; Jiang G; Huang H; Guo Z; Wang G
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 39028256
    [No Abstract]   [Full Text] [Related]  

  • 9. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
    Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
    Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.
    Zhang Z; Lu J; Wang Y; Pang Y; Zhao Y
    Antimicrob Agents Chemother; 2014; 58(1):364-9. PubMed ID: 24165186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High degree of fluoroquinolone resistance among extrapulmonary tuberculosis patients at a tertiary care center in North India.
    Chaubey J; Shrivastava D; Pawar S; Singh BK; Sharma R; Sinha S
    Int J Mycobacteriol; 2020; 9(3):309-312. PubMed ID: 32862166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
    Kabir S; Tahir Z; Mukhtar N; Sohail M; Saqalein M; Rehman A
    BMC Pulm Med; 2020 May; 20(1):138. PubMed ID: 32393213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype analysis of ofloxacin-resistant multidrug-resistant
    Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
    Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates.
    Ho J; Jelfs P; Sintchenko V
    Int J Infect Dis; 2014 Sep; 26():149-53. PubMed ID: 25086437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
    Verma JS; Nair D; Rawat D; Manzoor N
    Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
    Mather R; Karenchak LM; Romanowski EG; Kowalski RP
    Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.